Clinical Trial Update: Safety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by Lumpectomy [NA]

View source ↗

Summary

This clinical trial evaluates the safety and performance of the REGENERA Breast Implant in women with malignant breast lesions treated by lumpectomy; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• REGENERA Breast Implant

Snippet

Sponsor: Tensive SRL | Conditions: Mastectomy, Segmental, Breast Neoplasm Malignant Female | NA | Status: RECRUITING